ワルファリンとダビガトランの有効性と安全性の比較

基本情報

NCT ID

NCT03254134

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

22,490

治験依頼者名

Boehringer Ingelheim

概要

This is a comparative effectiveness and safety study of clinical events among patients taking either dabigatran or warfarin. There is no formal hypothesis to be tested, but rather to provide the estimates on the incidence of stroke and systemic embolism (effectiveness) and bleeding events (safety) using 95% confidence interval for comparison between those non0-valvular atrial fibrillation patients taking dabigatran vs. warfarin using a large, nation-wide claims data in Japan.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)